Drug
Soybean Oil
Soybean Oil: highest development phase Phase 3, developed by Fresenius Kabi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Fresenius Kabi
Trials
| Drug | Phase | Indication |
|---|---|---|
| Soybean oil (Standard treatment) NCT01565278 | Phase 3 | Total Parenteral Nutrition-induced Cholestasis |
Latest
No recent events.
Follow Soybean Oil on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.